Ophthalmologist Jorn S. Jorgensen, CEO and Founder of EuroEyes, Implanted EVO ICLs in His Son, Jannik Jorgensen LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that Dr. Jorn S. Jorgensen successfully implanted the Company’s EVO Visian ICL … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Neuronal Acetylcholine Receptor Subunit Alpha 7 – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Neuronal Acetylcholine Receptor Subunit Alpha 7 (CHRNA7) pipeline Target constitutes close to 16 molecules. Out of which approximately 14 molecules are developed by companies and remaining by the universities/institutes. The latest report Neuronal Acetylcholine … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Cholera – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical and Healthcare disease pipeline guide Cholera – Pipeline Review, H2 2019, provides an overview of the Cholera (Infectious Disease) pipeline landscape. Report Highlights This Pharmaceutical and Healthcare latest pipeline guide Cholera – Pipeline Review, H2 2019, … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Global Surgical Robotics Market: Focus on Product Type, Brand-Value Matrix, Regulatory Framework, Awaited Technological Advancements, Patent Analysis, Insights on Emerging Platforms in Pipeline, and 43 Countries’ Data – Analysis and Forecast, 2019-2029” report has been added to ResearchAndMarkets.com’s offering. The global surgical robotics market is anticipated to witness tremendous growth over the forecast … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Lyme Disease – Pipeline Review, H2 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The Lyme Disease – Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Lyme Disease (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$sage #SageRx–Sage Therapeutics (NASDAQ:SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Tuesday, November 12, 2019 at 8:00 a.m. EST to report its third quarter 2019 financial results and … [Read more…]
GAINESVILLE, Fla.–(BUSINESS WIRE)–#ConceptCompanies—Concept Companies, a Gainesville headquartered full-service real estate development and construction firm, has announced commencement of construction on a new office and lab building in Copeland Park for Lacerta Therapeutics, a clinical-stage gene therapy company. The 12,950 square foot building is expected to be completed in the Spring of 2020. Strategically located in … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Biomedical Temperature Sensors – Global Market Outlook (2017-2026)” report has been added to ResearchAndMarkets.com’s offering. The Global Biomedical Temperature Sensors market accounted for $5.6 billion in 2017 and is expected to reach $10.1 billion by 2026 growing at a CAGR of 6.8% during the forecast period. Some of the key factors influencing the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Diabetes Management: Insulin Pumps Market (2019)” report has been added to ResearchAndMarkets.com’s offering. The Global Insulin Pumps market is being driven by strong demand, increasing awareness and adoption of next-generation hybrid closed-loop systems, solid clinical outcomes, and good reimbursement. Market penetration is low, leaving much room for growth. According to the International Diabetes … [Read more…]
SAN DIEGO–(BUSINESS WIRE)–#biotech—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive, George Ng, Partner of PENG Life Science Ventures. His extensive background includes co-founding and leading the efforts of a pharmaceutical company from pre-clinical to clinical to New Drug … [Read more…]
